Search - tctmd.com

Displaying 1 - 20 of 772

Sort: Relevancy | Date

Presentation ACC 2026

IVUS or angiography guidance for PCI in complex coronary bifurcation lesions: The DKCRUSH VIII Trial

Presenter: Shao-Liang Chen

March 30, 2026

Presentation ACC 2026

THRIVE Food is Medicine Pilot Trial

Presenter: Oluwabunmi Ogungbe

March 30, 2026

Presentation ACC 2026

Sotatercept for Combined Post- and Pre-capillary Pulmonary Hypertension Associated With Heart Failure: Results From the Phase 2, Randomized, Placebo-Controlled CADENCE Study

Presenter: Mardi Gomberg-Maitland

March 29, 2026

Presentation ACC 2026

Groceries for Black Residents of Boston to Stop Hypertension among Adults with Treated Hypertension (GoFreshRx)

Presenter: Stephen Paul Juraschek

March 28, 2026

Presentation ACC 2026

KARDINAL: Efficacy and Safety of Tonlamarsen in Patients with Uncontrolled Hypertension

Presenter: Luke Laffin

March 28, 2026

Presentation THT Abstracts 2026

Impact of Pulmonary Hypertension Subtypes on Clinical Outcomes and Resource Utilization in Heart Failure

Presenter: Bryce Allen

March 03, 2026

Presentation THT 2026

Pulmonary Artery Denervation (PADN) Treatment in Patients with Pulmonary Hypertension Due to Left Heart Disease: Initial Results of the PreVail-PH2 Early Feasibility Study

Presenter: Ryan J. Tedford

March 03, 2026

Presentation THT Abstracts 2026

Impact of Pulmonary Hypertension Subtypes on Clinical Outcomes and Resource Utilization in Heart Failure

Presenter: Aarjuv Majmundar

March 02, 2026

Presentation THT 2026

Disentangling The Central, Peripheral And Hematological Mechanisms Of Benefit Of Sotatercept On Exercise Performance In Pulmonary Arterial Hypertension

Presenter: Yogesh Reddy

March 02, 2026

Presentation THT 2026

3-year changes in pulmonary artery pressures and pulmonary hypertension classification in remotely monitored heart failure patients

Presenter: Ryan J. Tedford

March 02, 2026

Presentation TCT 2025

Novel Structural Therapies for Pulmonary Hypertension: Balancing Safety, Functional Improvements, and Clinical Efficacy

Presenter: Daniel Burkhoff

October 28, 2025

Presentation TCT 2025

TCT 567: Response of Pulmonary Hypertension in Hypertrophic Obstructive Cardiomyopathy Patients Treated with Alcohol Septal Ablation

Presenter: Jorrian Abadeer

October 28, 2025

Presentation TCT 2025

Hypertension Guidelines

Presenter: Tara I. Chang

October 28, 2025

Presentation TCT 2025

TCT 1055: Innovative Mechanical Thrombectomy Approach: In Vivo Comparison of the Vicora Vibrato Device and Standard of Care in a Porcine Model

Presenter: Erin Marie Garcia

October 28, 2025

Presentation TCT 2025

TCT 1053: Right Ventricular Myocardial Performance Score as Potential Predictor of Response to Catheter Directed Thrombolytics for Acute Pulmonary Embolism

Presenter: Rohan Mundkur

October 28, 2025

Presentation TCT 2025

TCT 1054: Underutilization of Reperfusion Therapies in Women with Cancer Presenting with High-Risk Pulmonary Embolism

Presenter: Taru Bharadwaj

October 28, 2025

Presentation TCT 2025

TCT 1057: Blood Loss During Mechanical Thrombectomy for Acute Pulmonary Embolism: Does it Matter?

Presenter: Sripal Bangalore

October 28, 2025

Presentation TCT 2025

TCT 1052: Identifying High-Risk Pulmonary Embolism Patients Through Combined Hemodynamic and Thrombotic Assessment

Presenter: Marco G. Mennuni

October 28, 2025

Presentation TCT 2025

TCT 1050: Atrial flow regulator in patients with severe primary pulmonary arterial hypertension: The AFR PROPHET registry

Presenter: Jozef Bartunek

October 28, 2025

Presentation TCT 2025

TCT 1051: Catheter Directed Thrombolysis Versus Systemic Thrombolysis In Patients Admitted with Intermediate- or High-Risk Pulmonary Embolism and Contraindications to Lytic Therapy

Presenter: Rohan Mundkur

October 28, 2025

Advertisement

IVUS or angiography guidance for PCI in complex coronary bifurcation lesions: The DKCRUSH VIII Trial

THRIVE Food is Medicine Pilot Trial

Sotatercept for Combined Post- and Pre-capillary Pulmonary Hypertension Associated With Heart Failure: Results From the Phase 2, Randomized, Placebo-Controlled CADENCE Study

Groceries for Black Residents of Boston to Stop Hypertension among Adults with Treated Hypertension (GoFreshRx)

KARDINAL: Efficacy and Safety of Tonlamarsen in Patients with Uncontrolled Hypertension

Impact of Pulmonary Hypertension Subtypes on Clinical Outcomes and Resource Utilization in Heart Failure

Pulmonary Artery Denervation (PADN) Treatment in Patients with Pulmonary Hypertension Due to Left Heart Disease: Initial Results of the PreVail-PH2 Early Feasibility Study

Impact of Pulmonary Hypertension Subtypes on Clinical Outcomes and Resource Utilization in Heart Failure

Disentangling The Central, Peripheral And Hematological Mechanisms Of Benefit Of Sotatercept On Exercise Performance In Pulmonary Arterial Hypertension

3-year changes in pulmonary artery pressures and pulmonary hypertension classification in remotely monitored heart failure patients

Novel Structural Therapies for Pulmonary Hypertension: Balancing Safety, Functional Improvements, and Clinical Efficacy

TCT 567: Response of Pulmonary Hypertension in Hypertrophic Obstructive Cardiomyopathy Patients Treated with Alcohol Septal Ablation

Hypertension Guidelines

TCT 1055: Innovative Mechanical Thrombectomy Approach: In Vivo Comparison of the Vicora Vibrato Device and Standard of Care in a Porcine Model

TCT 1053: Right Ventricular Myocardial Performance Score as Potential Predictor of Response to Catheter Directed Thrombolytics for Acute Pulmonary Embolism

TCT 1054: Underutilization of Reperfusion Therapies in Women with Cancer Presenting with High-Risk Pulmonary Embolism

TCT 1057: Blood Loss During Mechanical Thrombectomy for Acute Pulmonary Embolism: Does it Matter?

TCT 1052: Identifying High-Risk Pulmonary Embolism Patients Through Combined Hemodynamic and Thrombotic Assessment

TCT 1050: Atrial flow regulator in patients with severe primary pulmonary arterial hypertension: The AFR PROPHET registry

TCT 1051: Catheter Directed Thrombolysis Versus Systemic Thrombolysis In Patients Admitted with Intermediate- or High-Risk Pulmonary Embolism and Contraindications to Lytic Therapy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content